The Structural Bases of Antibiotic Resistance in the Clinically Derived Mutant β-Lactamases TEM-30, TEM-32, and TEM-34*

Widespread use of β-lactam antibiotics has promoted the evolution of β-lactamase mutant enzymes that can hydrolyze ever newer classes of these drugs. Among the most pernicious mutants are the inhibitor-resistant TEM β-lactamases (IRTs), which elude mechanism-based inhibitors, such as clavulanate. Despite much research on these IRTs, little is known about the structural bases of their action. This has made it difficult to understand how many of the resistance substitutions act as they often occur far from Ser-130. Here, three IRT structures, TEM-30 (R244S), TEM-32 (M69I/M182T), and TEM-34 (M69V), are determined by x-ray crystallography at 2.00, 1.61, and 1.52 Å, respectively. In TEM-30, the Arg-244 → Ser substitution (7.8 Å from Ser-130) displaces a conserved water molecule that usually interacts with the β-lactam C3 carboxylate. In TEM-32, the substitution Met-69 → Ile (10 Å from Ser-130) appears to distort Ser-70, which in turn causes Ser-130 to adopt a new conformation, moving its Oγ further away, 2.3 Å from where the inhibitor would bind. This substitution also destabilizes the enzyme by 1.3 kcal/mol. The Met-182 → Thr substitution (20 Å from Ser-130) has no effect on enzyme activity but rather restabilizes the enzyme by 2.9 kcal/mol. In TEM-34, the Met-69 → Val substitution similarly leads to a conformational change in Ser-130, this time causing it to hydrogen bond with Lys-73 and Lys-234. This masks the lone pair electrons of Ser-130 Oγ, reducing its nucleophilicity for cross-linking. In these three structures, distant substitutions result in accommodations that converge on the same point of action, the local environment of Ser-130.

[1]  L. Bret,et al.  Inhibitor-resistant TEM (IRT) beta-lactamases with different substitutions at position 244 , 1997, Antimicrobial agents and chemotherapy.

[2]  K. Bush,et al.  Kinetic interactions of tazobactam with beta-lactamases from all major structural classes , 1993, Antimicrobial Agents and Chemotherapy.

[3]  G. Paul,et al.  Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. , 1999, The Journal of antimicrobial chemotherapy.

[4]  R. Labia,et al.  Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modelling. , 1998, Biochimica et biophysica acta.

[5]  Wanzhi Huang,et al.  A natural polymorphism in beta-lactamase is a global suppressor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Patrice Courvalin,et al.  Stability of TEM β‐lactamase mutants hydrolyzing third generation cephalosporins , 1995 .

[7]  Brian K Shoichet,et al.  Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. , 2002, Journal of molecular biology.

[8]  J M Masson,et al.  Crystal structure of Escherichia coli TEM1 β‐lactamase at 1.8 Å resolution , 1993, Proteins.

[9]  T. Palzkill,et al.  A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J M Ghuysen,et al.  A standard numbering scheme for the class A beta-lactamases. , 1991, The Biochemical journal.

[11]  J. Knowles Penicillin resistance: the chemistry of .beta.-lactamase inhibition , 1985 .

[12]  R. Huber,et al.  Accurate Bond and Angle Parameters for X-ray Protein Structure Refinement , 1991 .

[13]  J. Knox,et al.  Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure , 1995, Antimicrobial agents and chemotherapy.

[14]  J. Frère,et al.  β‐Lactamase of Bacillus licheniformis 749/C at 2 Å resolution , 1990 .

[15]  J. Knowles,et al.  Chemical studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid. , 1978, Biochemistry.

[16]  B. Matthews,et al.  Control of enzyme activity by an engineered disulfide bond. , 1994, Science.

[17]  C. Schofield,et al.  Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry. , 1996, Biochemistry.

[18]  F. Baquero,et al.  Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase , 1996, Antimicrobial agents and chemotherapy.

[19]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[20]  B. Shoichet,et al.  An ultrahigh resolution structure of TEM-1 beta-lactamase suggests a role for Glu166 as the general base in acylation. , 2002, Journal of the American Chemical Society.

[21]  B. Shoichet,et al.  Noncovalent interaction energies in covalent complexes: TEM‐1 β‐lactamase and β‐lactams , 2002 .

[22]  S. Cabantous,et al.  X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid. , 1999, Biochemistry.

[23]  Eric M. Billings,et al.  Inactivation of class A β-lactamases by clavulanic acid : the role of arginine-244 in a proposed nonconcerted sequence of events , 1993 .

[24]  R. Bonomo,et al.  Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam. , 2001, Biochemistry.

[25]  M. Siegel,et al.  Mechanism of inhibition of the class A beta -lactamases PC1 and TEM-1 by tazobactam. Observation of reaction products by electrospray ionization mass spectrometry. , 2000, The Journal of biological chemistry.

[26]  W. J. Becktel,et al.  Protein stability curves , 1987, Biopolymers.

[27]  C. Betzel,et al.  Molecular structure of the acyl-enzyme intermediate in β-lactam hydrolysis at 1.7 Å resolution , 1992, Nature.

[28]  F. Baquero,et al.  Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli , 1993, Antimicrobial Agents and Chemotherapy.

[29]  J. Frère,et al.  Catalytic mechanism of active-site serine beta-lactamases: role of the conserved hydroxy group of the Lys-Thr(Ser)-Gly triad. , 1994, The Biochemical journal.

[30]  S. Mobashery,et al.  Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 beta-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime , 1994, Antimicrobial Agents and Chemotherapy.

[31]  G. Paul,et al.  Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). , 1994, FEMS microbiology letters.

[32]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[33]  J. Samama,et al.  Site-directed mutagenesis at the active site of Escherichia coli TEM-1 beta-lactamase. Suicide inhibitor-resistant mutants reveal the role of arginine 244 and methionine 69 in catalysis. , 1992, The Journal of biological chemistry.

[34]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[35]  J. Knowles,et al.  Inactivation of RTEM beta-lactamase from Escherichia coli by clavulanic acid and 9-deoxyclavulanic acid. , 1981, Biochemistry.

[36]  J. Condra,et al.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors , 1995, Nature.

[37]  Youjun Yang,et al.  Class A β-lactamases—enzyme-inhibitor interactions and resistance , 1999 .

[38]  W. Huse,et al.  Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties. , 1988, Nucleic acids research.

[39]  S. Mobashery,et al.  Elucidation of the role of arginine-244 in the turnover processes of class A beta-lactamases. , 1992, Biochemistry.

[40]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[41]  O. Herzberg,et al.  Inhibition of beta-lactamase by clavulanate. Trapped intermediates in cryocrystallographic studies. , 1992, Journal of molecular biology.